Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly M Bailey

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Hematology/Oncology|February 2, 2023
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver DiseaseJessica Daley, Katharine Halligan, Denise Howrie, et al.
Journal of Pediatric Hematology/Oncology|July 20, 2012
Thalidomide therapy for aggressive histiocytic lesions in the pediatric populationKelly M Bailey, Valerie P Castle, Jennifer M Hummel, et al.
JCO Precision Oncology|August 25, 2020
DICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric OncologyKelly M Bailey, Michelle F Jacobs, Bailey Anderson, et al.
Journal of Pediatric Hematology/Oncology|April 15, 2022
Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a ChildJessica Daley, Nathan Williams, Claudia M Salgado, et al.
Oncotarget|June 6, 2019
EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosisKelly M Bailey, Claire M Julian, Ariel N Klinghoffer, et al.
Translational Pediatrics|August 31, 2018
Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysisKelly M Bailey, Alison B Durham, Lili Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade ResistanceJessica D Daley, Elina Mukherjee, David Ferraro, et al.
Pediatric Blood & Cancer|June 4, 2019
A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counselingRosemarie E Venier, Lisa M Maurer, Elena M Kessler, et al.
Pediatric Blood & Cancer|January 19, 2026
Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing SarcomaMolly Mack, A Carolina Tufino, Mohd Azrin Jamalruddin, et al.
Nature Cell Biology|January 19, 2023
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activationYuan Gao, Xue-Yan He, Xiaoli S Wu, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Hematology/Oncology|February 2, 2023
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver DiseaseJessica Daley, Katharine Halligan, Denise Howrie, et al.
Journal of Pediatric Hematology/Oncology|July 20, 2012
Thalidomide therapy for aggressive histiocytic lesions in the pediatric populationKelly M Bailey, Valerie P Castle, Jennifer M Hummel, et al.
JCO Precision Oncology|August 25, 2020
DICER1 Mutations in the Era of Expanding Integrative Clinical Sequencing in Pediatric OncologyKelly M Bailey, Michelle F Jacobs, Bailey Anderson, et al.
Journal of Pediatric Hematology/Oncology|April 15, 2022
Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a ChildJessica Daley, Nathan Williams, Claudia M Salgado, et al.
Oncotarget|June 6, 2019
EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosisKelly M Bailey, Claire M Julian, Ariel N Klinghoffer, et al.
Translational Pediatrics|August 31, 2018
Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysisKelly M Bailey, Alison B Durham, Lili Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade ResistanceJessica D Daley, Elina Mukherjee, David Ferraro, et al.
Pediatric Blood & Cancer|June 4, 2019
A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counselingRosemarie E Venier, Lisa M Maurer, Elena M Kessler, et al.
Pediatric Blood & Cancer|January 19, 2026
Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing SarcomaMolly Mack, A Carolina Tufino, Mohd Azrin Jamalruddin, et al.
Nature Cell Biology|January 19, 2023
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activationYuan Gao, Xue-Yan He, Xiaoli S Wu, et al.
Pageof 4